Why We Are Joining the UN Global Compact as Part of Our Broader Strategy

Learn how BTG Pharmaceuticals, a SERB company, is becoming better environmental stewards, more responsive to our people and respectful of our responsibilities as an organisation

In our work with healthcare providers across the country, our purpose has always been to ease the suffering of those living with critical conditions. Now, as part of our broader mission to create a world with less suffering, we have recently signed on to the United Nations Global Compact—an agreement to align our business strategies with ten principles covering human rights, labor, the environment and anti-corruption.

Our participation comes at a critical time. As SERB, BTG Specialty Pharmaceuticals and Veriton converge on a shared purpose and set of values, it has become increasingly clear that environmental, social and governance (ESG) topics and sustainability principles are central to how we operate. Our legacy companies have worked on several ESG-aligned projects over the last decade, spanning from solar panel installations to partnerships with life-saving organizations like the Asclepius Snakebite Foundation.

Committing to the UN Global Compact is a natural extension of these efforts. Here’s how we plan to get started.

How We Plan to Meet Our UN Global Compact and ESG Goals

Changing for the Better

By making a commitment to uphold our fundamental responsibilities to people and the planet, we are living out our stated values and fulfilling our purpose as an organization. Not only is this approach important to stakeholders, but it’s essential to the continued success of our company.

Most importantly, signing up for the UN Global Compact is a gesture of solidarity with our employees, who bring a variety of unique backgrounds, experiences and identities to the table. Together, we have seen how environmental and social issues have come to the foreground of the national conversation, and why it’s crucial that companies respond swiftly to ESG-related concerns. As a new generation of employees and job candidates enter the workforce, this new focus on corporate responsibility will be central to building a fair and a sustainable company.

About SERB Pharmaceuticals

SERB is a growing pharmaceutical group and a dedicated ally to healthcare providers treating patients with critical conditions, focusing on emergency care and rare diseases. For over 30 years we have made treating these complex and life-threatening conditions possible, supporting clinicians, healthcare systems and governments while offering hope to patients and their families. SERB operates as BTG Pharmaceuticals in the United States. As a fully integrated company, we have the experience and capabilities to acquire, develop, and manufacture our medicines to the highest standards, and make them available worldwide through our secure supply chain.